Liver Cirrhosis Quiz

Check your symptoms and
find possible causes with AI for free

Worried about your symptoms?

Start the Liver Cirrhosis test with our free AI Symptom Checker.

This will help us personalize your assessment.

Shiba

By starting the symptom checker, you agree to the Privacy Policy and Terms of Use

Capillaries can be seen on the face

Frequent nighttime urination

Liver failure

Fatigued

Frequent urination

Gained weight

Swelling

Not seeing your symptoms? No worries!

What is Liver Cirrhosis?

Cirrhosis refers to scarring of the liver which results in abnormal liver function as a consequence of chronic (long-term) liver injury. There are many different causes including infections, alcohol abuse, inherited disorders, and fatty liver.

Typical Symptoms of Liver Cirrhosis

Diagnostic Questions for Liver Cirrhosis

Your doctor may ask these questions to check for this disease:

  • Do you have visible veins on your stomach?
  • Are your nails white around the base?
  • Have you noticed an unusual increase in your breast size?
  • Have you been diagnosed with ascites?
  • Does the swelling leave a dent when pressed for at least 15 seconds?

Treatment of Liver Cirrhosis

Medical care for patients with cirrhosis has several aims: (1) treating the underlying cause of liver disease when possible, (2) preventing cirrhosis-related complications, and (3) treating the symptoms of cirrhosis. Cirrhosis is a chronic disease, and patients with cirrhosis require ongoing medical care with a physician specializing in the care of patients with liver disease. In severe cases, a liver transplant may be the only effective treatment.

Reviewed By:

Samantha Nazareth, MD

Samantha Nazareth, MD (Gastroenterology)

Board-certified gastroenterologist. Experience managing gastrointestinal conditions (GERD, IBS, ulcerative colitis, Crohn’s, celiac disease, NASH) within healthcare organizations (three ambulatory surgical centers, single-specialty practice, multi-specialty practice and solo practice).

Aiko Yoshioka, MD

Aiko Yoshioka, MD (Gastroenterology)

Dr. Yoshioka graduated from the Niigata University School of Medicine. He worked as a gastroenterologist at Saiseikai Niigata Hospital and Niigata University Medical & Dental Hospital before serving as the Deputy Chief of Gastroenterology at Tsubame Rosai Hospital and Nagaoka Red Cross Hospital. Dr. Yoshioka joined Saitama Saiseikai Kawaguchi General Hospital as Chief of Gastroenterology in April 2018.

From our team of 50+ doctors

Content updated on Feb 19, 2025

Following the Medical Content Editorial Policy

Was this page helpful?

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

Think you might have
Liver Cirrhosis?

Try a symptom check test

How Ubie Can Help You

With a free 3-min Liver Cirrhosis quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.

This questionnaire is customized to your situation and symptoms, including the following personal information:

  • Biological Sex - helps us provide relevant suggestions for male vs. female conditions.

  • Age - adjusts our guidance based on any age-related health factors.

  • History - considers past illnesses, surgeries, family history, and lifestyle choices.

Your symptoms

Input your symptoms

Our AI

Our AI checks your symptoms

Your report

You get your personalized report

Your personal report will tell you

✔  When to see a doctor

✔︎  What causes your symptoms

✔︎  Treatment information etc.

People with similar symptoms also use Ubie's symptom checker to find possible causes

See full list

Symptoms Related to Liver Cirrhosis

Diseases Related to Liver Cirrhosis

FAQs

Q.

Is Your Liver Enlarged? Why Hepatomegaly Occurs & Medical Next Steps

A.

An enlarged liver, or hepatomegaly, is a sign rather than a diagnosis, most often from fatty liver or hepatitis but also from cirrhosis, heart failure, cancer, infections, or inherited disorders; many causes are reversible if caught early, but how serious it is depends on the cause. Evaluation usually involves blood tests and imaging, targeted treatment of the cause, and urgent care for red flags like jaundice, severe abdominal pain, confusion, or vomiting blood; there are several factors to consider that could change your next steps, so see the complete guidance below for the key tests, timelines, and treatment options.

References:

* Kim JK, Almenawer S, Grewal V, Al-Busafi SA. Approach to the Patient With Hepatomegaly. Clin Liver Dis. 2023 Feb;27(1):15-27. doi: 10.1016/j.cld.2022.08.003. Epub 2022 Nov 10. PMID: 36394602.

* Aljebreen AM, Alalwan SM, Alharbi AM, Alosaimi NM, Alfahad ZA, Alyousef AM, Alsaleh EA. Etiology of Hepatomegaly in Adult Patients: A Review. Cureus. 2023 Oct 29;15(10):e47936. doi: 10.7759/cureus.47936. PMID: 36442657; PMCID: PMC10684705.

* Shukla B, Agrawal M, Khan M, Alsaedi SM, Aljohani H, Singh A, Alqudah M, Alsulami O, Alamri A, Albalawi M, Alasmari A. Hepatomegaly and Its Causes in Children and Adults. Cureus. 2022 Dec 19;14(12):e32662. doi: 10.7759/cureus.32662. PMID: 36696348; PMCID: PMC9858547.

* Choudhary B, Nandy P, Biswas S, Singh VK. Hepatomegaly: a Review of Etiology, Evaluation, and Management. Cureus. 2021 Jul 19;13(7):e16508. doi: 10.7759/cureus.16508. PMID: 34360341; PMCID: PMC8333552.

* Al-Busafi SA, Al-Ghamdi A, Qarni Z, Al-Abbad M, Qannadi F, Alshahrani A, Mofleh A. Evaluation of the adult patient with hepatomegaly. Can J Gastroenterol. 2013 May;27(5):291-6. doi: 10.1155/2013/674068. PMID: 23793699; PMCID: PMC3735166.

See more on Doctor's Note

Q.

Is Cirrhosis of the Liver Reversible? Why Your Body Fails + Medically Approved Next Steps

A.

Early cirrhosis may be partially reversible, while advanced cirrhosis is usually permanent; even then, addressing the cause, regular monitoring, medications for complications, and targeted lifestyle changes can often slow or stop further damage. There are several factors to consider, including why the body fails in cirrhosis, red flag symptoms, cancer screening, and when transplant is needed; see below for medically approved next steps and what to discuss with your doctor.

References:

* Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Pathophysiology of Cirrhosis. N Engl J Med. 2021 Mar 4;384(9):839-851. doi: 10.1056/NEJMra2023537. PMID: 33657217.

* Gines P, Cardenas A, Arroyo V, Quintero E. Management of Cirrhosis and Its Complications: Evidence and Guidelines. Gastroenterology. 2020 Jul;159(1):9-29.e1. doi: 10.1053/j.gastro.2020.03.042. PMID: 32247657.

* Wang Y, Zheng X, Wang B, Li J, Wei L, Ma X. Reversibility of Cirrhosis and Fibrosis: Myth or Reality? J Clin Transl Hepatol. 2017 Mar 28;5(1):61-69. doi: 10.14218/JCTH.2016.00072. PMID: 28451558; PMCID: PMC5390708.

* Iredale JP. Reversibility of liver fibrosis and cirrhosis. J Hepatol. 2015 Mar;62(3):477-90. doi: 10.1016/j.jhep.2014.10.003. PMID: 25416035.

* Schuppan D, Afdhal NH. Cirrhosis: mechanisms and management. Lancet. 2014 Dec 13;384(9959):2016-2028. doi: 10.1016/S0140-6736(14)60756-8. PMID: 25435424.

See more on Doctor's Note

Q.

Confused by MASH? Why Your Liver Is Scarring & Medical Next Steps

A.

MASH is a serious form of fatty liver disease caused by metabolic dysfunction that leads to fat buildup, inflammation, and scarring, which can progress to fibrosis or cirrhosis but often improves with weight loss, better blood sugar and cholesterol control, regular exercise, and limiting alcohol. Next steps typically include confirming your fibrosis stage with blood-based scores and imaging like FibroScan, close follow up with your doctor, and discussing medications or a hepatology referral if fibrosis is moderate to advanced. There are several factors and red flag symptoms to consider, including jaundice, swelling, vomiting blood, or confusion that warrant urgent care, so see the complete guidance below to choose the right actions now.

References:

* Singh, G., Sanyal, A.J., Noureddin, M., & Rinella, M.E. (2023). Metabolic dysfunction-associated steatohepatitis (MASH): A new disease entity and clinical implications. *Experimental Biology and Medicine (Maywood)*, 248(3), 209-221.

* Uddin, S. M. S., Ganda, N. K., Singh, S., Khadka, R., Kandel, R., Sharma, P., Baniya, G., Adhikari, K., Poudel, K., Pandey, S., Gupta, N., Singh, R., Thapa, S., Dahal, K. R., & Sreeram, V. (2023). Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH): An update on pathogenesis, diagnosis and treatment. *World Journal of Gastroenterology*, 29(30), 4641-4660.

* Ho, N. C. T., Ho, D. K. S., & George, J. (2023). Metabolic dysfunction-associated steatohepatitis: natural history, diagnosis, and management. *Expert Review of Gastroenterology & Hepatology*, 17(12), 1187-1200.

* Chan, H. L., Kwok, R. M. C., Wong, V. W. S., & Yki-Järvinen, H. (2023). Noninvasive Assessment of Fibrosis in Metabolic Dysfunction-Associated Steatohepatitis (MASH): A State-of-the-Art Review. *Journal of Clinical and Translational Hepatology*, 11(6), 1140-1153.

* Harrison, S. A., & Sanyal, A. J. (2023). Pharmacological Treatments for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Current Landscape and Future Directions. *Clinics in Liver Disease*, 27(4), 793-808.

See more on Doctor's Note

Q.

Cirrhosis? Why Your Liver Is Scarring and Medically Approved Next Steps

A.

Cirrhosis is progressive scarring of the liver from repeated injury due to heavy alcohol use, chronic hepatitis B or C, fatty liver linked to obesity and diabetes, autoimmune or genetic diseases, or long-term bile duct problems; early stages can be silent, while advanced disease can cause jaundice, swelling, easy bruising or bleeding, dark urine, pale stools, itching, and confusion. Medically approved next steps focus on treating the cause, completely stopping alcohol, targeted lifestyle changes like weight management and low sodium if swelling is present, safe medication use under a doctor’s guidance, regular monitoring for liver cancer and enlarged veins, and transplant evaluation when needed. There are several factors to consider, including urgent red flags and tests your doctor may recommend. See below for the complete guidance that can impact which next steps you take.

References:

* Ge J, Zhao X, Li Y, Han X, Li B. Cirrhosis: Definition, Etiology, Pathophysiology, Diagnosis, and Management. J Clin Transl Hepatol. 2023 Dec 28;11(6):1598-1610. doi: 10.14218/JCTH.2023.00073. Epub 2023 Jul 26. PMID: 38205096; PMCID: PMC10777170.

* Trebicka J, Fernandez J, Laleman W, Moller S, Polese L, Putignano A, Sarin SK, Sogaard KK, Tsochatzis E. Recent advances in understanding the pathogenesis of cirrhosis and portal hypertension. Lancet Gastroenterol Hepatol. 2024 Feb;9(2):162-177. doi: 10.1016/S2468-1253(23)00292-0. Epub 2023 Nov 17. PMID: 37984814.

* Garcia-Tsao G, Lim JK, Nadal J. New insights into the pathophysiology and management of cirrhosis. Ann Transl Med. 2020 Feb;8(3):93. doi: 10.21037/atm.2020.01.21. PMID: 32320701; PMCID: PMC7164284.

* American Association for the Study of Liver Diseases. Management of Cirrhosis and Its Complications: Evidence-Based Recommendations from the American Association for the Study of Liver Diseases. Hepatology. 2024 Jan 1;79(1):4-60. doi: 10.1097/HEP.0000000000000632. Epub 2023 Oct 26. PMID: 37883296.

* Kisseleva T, Brenner DA. Hepatic stellate cells and the resolution of liver fibrosis. Gastroenterology. 2021 May;160(6):1976-1988. doi: 10.1053/j.gastro.2021.01.002. PMID: 33453303; PMCID: PMC8077556.

See more on Doctor's Note

Q.

Is It Just Fatigue? Why Liver Disease Is Silent + Medically Approved Next Steps

A.

Persistent, unexplained fatigue can be a subtle early sign of liver disease, which is often silent until damage is advanced. There are several factors to consider, including companion signs like appetite changes, nausea, swelling, jaundice, or mental fog, and risks such as diabetes, obesity, alcohol use, medications, or viral hepatitis. Medically approved next steps include arranging blood tests and imaging with a clinician, reviewing your risks and medications, starting liver supportive habits, avoiding unverified supplements, and asking about hepatitis vaccines; seek urgent care for jaundice, severe swelling, vomiting blood, black stools, or confusion. For complete guidance and how to choose your next step, see below.

References:

* pubmed.ncbi.nlm.nih.gov/31867160/

* pubmed.ncbi.nlm.nih.gov/33910609/

* pubmed.ncbi.nlm.nih.gov/27040439/

* pubmed.ncbi.nlm.nih.gov/29991448/

* pubmed.ncbi.nlm.nih.gov/28546377/

See more on Doctor's Note

Q.

Scared of Hepatic Steatosis? Why Your Liver Stores Fat & Medical Next Steps

A.

Hepatic steatosis means your liver is storing excess fat, most often from metabolic factors like insulin resistance, obesity, high triglycerides, or alcohol, and while many people have no symptoms, it can progress from simple fat to inflammation, scarring, cirrhosis, and even cancer if not addressed. The good news is that it is often reversible with weight loss, a Mediterranean-style diet, regular exercise, tight blood sugar and lipid control, and limiting or avoiding alcohol. Smart next steps include confirming the type and stage, assessing fibrosis risk, reviewing diabetes, cholesterol, and blood pressure, creating a realistic lifestyle plan, and knowing red flag symptoms such as jaundice, swelling, confusion, or severe fatigue that need urgent care. There are several factors to consider, including which tests to request and when medications or supplements may help or harm, so see the complete details below.

References:

* Scherbov, I., Hrytsiuk, M., Dmytriiev, D., Koval, H., & Bilous, I. (2023). Mechanisms of Hepatic Steatosis. *International Journal of Molecular Sciences*, *24*(23), 16869.

* Perseghin, G., D'Amico, M., De Leo, S., Marra, M., Ciardullo, S., & Luzi, L. (2022). Non-Invasive Diagnostic Tests for Non-Alcoholic Fatty Liver Disease. *Journal of Clinical Medicine*, *11*(6), 1699.

* Rinella, M. E., Lazarus, J. V., Ratziu, V., Noureddin, M., Gottlieb, A., Lin, S., ... & Newsome, P. N. (2023). AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. *Hepatology*, *78*(3), 882-911.

* Eslam, M., Newsome, P. N., & Sarin, S. K. (2022). Lifestyle modifications for the management of nonalcoholic fatty liver disease: An updated review. *JGH Open*, *6*(2), 105-115.

* Arroyo, V., Argüello, M., & Fernández, E. R. (2023). Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Comprehensive Update. *Cells*, *12*(17), 2162.

See more on Doctor's Note

Q.

Fatty Liver Disease? Why Your Liver is Storing Fat & Medically Approved Steps

A.

Fatty liver disease happens when the liver stores excess fat, most often due to insulin resistance, excess calories and sugar, abdominal weight, alcohol, high triglycerides, and genetics; it is common, often silent early, and frequently reversible. Medically proven steps include losing 5 to 10 percent of body weight, a Mediterranean-style diet that cuts added sugars, regular aerobic and strength exercise, controlling blood sugar and triglycerides, and limiting or avoiding alcohol, with ongoing follow up with your clinician. There are several factors to consider, and important details below can affect testing, monitoring, and which next steps are right for you.

References:

* pubmed.ncbi.nlm.nih.gov/32249563/

* pubmed.ncbi.nlm.nih.gov/35058288/

* pubmed.ncbi.nlm.nih.gov/34185566/

* pubmed.ncbi.nlm.nih.gov/32677271/

* pubmed.ncbi.nlm.nih.gov/36774436/

See more on Doctor's Note

Q.

Fatty Liver? Why Your Liver is Storing Fat & Medically Approved Next Steps

A.

Fatty liver occurs when too much fat builds up in liver cells, most often due to insulin resistance, excess weight, high sugar and refined carbs, alcohol, and abnormal blood lipids; it often has no symptoms, can progress to inflammation and scarring, and is frequently reversible when addressed early. Medically approved next steps include losing 5 to 10 percent of body weight, following a Mediterranean-style whole-food diet, exercising at least 150 minutes a week with strength training, optimizing blood sugar and cholesterol, limiting or avoiding alcohol, reviewing medications, and monitoring with labs and imaging. There are several factors to consider that can change which actions are best for you; see the complete guidance below to choose the right next steps with your clinician.

References:

* Idilman, K. C. C., et al. (2023). AASLD Practice Guidance on the Clinical Assessment and Management of Nonalcoholic Fatty Liver Disease. *Hepatology*, 78(1), 160-192.

* Tilg, H., et al. (2022). Pathogenesis of non-alcoholic fatty liver disease: current knowledge and clinical implications. *Nature Reviews Gastroenterology & Hepatology*, 19(11), 748-763.

* Friedman, K. E., et al. (2022). Pathophysiology and management of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. *Journal of Clinical Endocrinology & Metabolism*, 107(3), 606-621.

* Katsiki, A., et al. (2020). The Role of Lifestyle Modifications in the Management of Nonalcoholic Fatty Liver Disease: A Narrative Review. *Nutrients*, 12(7), 2117.

* Tan, K. L. C., et al. (2021). Non-alcoholic fatty liver disease: Pathogenesis, diagnosis, and treatment. *World Journal of Gastroenterology*, 27(34), 5649-5661.

See more on Doctor's Note

Q.

Is it Cirrhosis? Why Your Liver is Scarring & Medically Approved Next Steps

A.

Cirrhosis is long-term liver scarring from alcohol, fatty liver related to obesity and diabetes, viral hepatitis, and other conditions; early disease may be silent, then cause swelling, jaundice, easy bleeding, or confusion, and doctors confirm it with blood tests, imaging, and sometimes biopsy. While advanced scarring cannot be reversed, early injury may improve and progression can be slowed with medically approved steps like urgent care for red flags, complete alcohol abstinence, managing metabolic risks, vaccinations, safe medication use, regular surveillance, and transplant evaluation when needed; there are several factors to consider, and key details that could change your next steps are explained below.

References:

* Gines P, Cardenas A, Arroyo V, Quintero E. Diagnosis and staging of liver fibrosis and cirrhosis. Semin Liver Dis. 2021 Feb;41(1):15-32. doi: 10.1055/s-0040-1721867. Epub 2021 Jan 27. PMID: 33501712.

* Kisseleva T, Brenner DA. Molecular mechanisms of liver fibrosis: from chronic injury to liver cancer. J Clin Invest. 2021 Jul 15;131(14):e147573. doi: 10.1172/JCI147573. PMID: 34198270; PMCID: PMC8278297.

* Sarin SK, Choudhury A, Sharma MK, Saraf N, Kumar S, Gupta P. Diagnosis and Management of Cirrhosis and Its Complications: A Concise Review. Clin Gastroenterol Hepatol. 2020 Jul;18(8):1733-1741. doi: 10.1016/j.cgh.2019.12.029. Epub 2020 Jan 2. PMID: 31901768.

* Bajaj JS, O'Leary JG, Pinkerton A, Wong RJ, Garcia-Tsao G. Management of Patients With Decompensated Cirrhosis: 2023 AASLD Practice Guidance. Hepatology. 2023 Oct 1;78(4):1127-1175. doi: 10.1097/HEP.0000000000000494. Epub 2023 May 17. PMID: 37196654.

* Schuppan D, Polyak SJ, Afdhal NH, et al. Reversibility of Fibrosis and Cirrhosis. Gastroenterology. 2023 Apr;164(5):677-695. doi: 10.1053/j.gastro.2023.01.037. PMID: 36764720.

See more on Doctor's Note

Q.

Is it Liver Damage? Why Your Liver is Failing + Medically Approved Next Steps

A.

Liver damage can happen silently and is most often caused by fatty liver disease, alcohol, viral hepatitis, autoimmune disease, medications or toxins, or genetic disorders; early symptoms are subtle, while jaundice, swelling, dark urine, pale stools, easy bruising, or confusion signal advanced disease and need prompt care. Medically approved next steps include seeing a doctor for liver blood tests and imaging, stopping alcohol, reviewing medications, improving metabolic health and weight, treating hepatitis or autoimmune causes, and getting recommended hepatitis vaccines. There are several factors to consider that could change your next steps, so see the complete details below.

References:

* Jalan R, et al. Acute Liver Failure: A Clinical Review. Semin Liver Dis. 2021 Aug;41(4):460-474. PMID: 34392476.

* Ginès P, et al. Management of Cirrhosis and Its Complications. Nat Rev Gastroenterol Hepatol. 2021 Jul;18(7):476-490. PMID: 34040228.

* Younossi ZM, et al. Nonalcoholic Fatty Liver Disease (NAFLD): A Review. JAMA. 2019 Nov 26;322(20):2009-2018. PMID: 31794174.

* Sarin SK, et al. Alcoholic Liver Disease. Lancet Gastroenterol Hepatol. 2020 Feb;5(2):167-185. PMID: 31839556.

* Luu N, et al. Liver transplantation: Current challenges and future prospects. World J Hepatol. 2023 Feb 27;15(2):100-109. PMID: 36814389.

See more on Doctor's Note

Q.

Cirrhosis of the Liver in Women: Key Symptoms & Your Action Plan

A.

Cirrhosis in women often begins silently with fatigue, appetite loss, itchy skin, easy bruising, or menstrual irregularities, then can advance to jaundice, abdominal or leg swelling, pale stools or dark urine, confusion, and hormone changes. There are several factors to consider, from common causes like fatty liver, alcohol, viral hepatitis, and autoimmune disease to urgent red flags such as vomiting blood or sudden confusion and how to act on them. See below for the full action plan, testing and follow-up guidance, and treatment options that could affect your next steps.

References:

* Jansen C, Horvatits T, Drolz A, Wischmeyer P, Rutter K, Trauner M, Reiberger T, Bucsics T. Sex Differences in Clinical Presentation and Outcomes of Cirrhosis. Eur J Gastroenterol Hepatol. 2017 Jul;29(7):837-844. doi: 10.1097/MEG.0000000000000889. PMID: 28489624.

* Moreira AC, Boscaini M, Vizzutti F, Garcia-Tsao G, Tsochatzis EA, Valla D, Lencioni R, Tana M, Cammà C, Riccaboni M, Majumdar A, Marchesini G, Romanelli RG. Sex-Related Differences in Cirrhosis: Focus on Diagnosis, Prognosis, and Treatment. Cells. 2023 Feb 15;12(4):653. doi: 10.3390/cells12040653. PMID: 36831411; PMCID: PMC9953835.

* Buccola L, Trevisani F, Andreone P. Sex Differences in Advanced Chronic Liver Disease and Its Complications. J Clin Med. 2020 Jan 22;9(2):297. doi: 10.3390/jcm9020297. PMID: 31979401; PMCID: PMC7073719.

* Walia A, Balasubramanian S, Terrault NA. Sex and gender issues in chronic liver diseases. Transl Gastroenterol Hepatol. 2021 May 28;6:29. doi: 10.21037/tgh-2020-07. PMID: 34189284; PMCID: PMC8181676.

* Marchesini G, Boscaini M, Iannone A, Tana M, Vizzutti F, Romanelli RG. Sex-specific differences in health-related quality of life in patients with cirrhosis. Liver Int. 2017 Jul;37(7):1063-1070. doi: 10.1111/liv.13328. PMID: 27901248.

See more on Doctor's Note

Q.

What actually kills you when you have stage 3 cirrhosis of the liver?

A.

The immediate causes of death in stage 3 cirrhosis include variceal bleeding, spontaneous bacterial peritonitis with sepsis, hepatorenal syndrome, severe hepatic encephalopathy, and hepatocellular carcinoma, often triggering a cascade into multi organ failure. There are several factors to consider. See below for early warning signs to act on and key steps that reduce risk, guide monitoring, and inform when to seek urgent care or transplant evaluation.

References:

D'Amico G, Garcia‐Tsao G, & Pagliaro L. (2006). Natural history and prognostic indicators of survival in cirrhosis: a syste… J Hepatol, 16469710.

Jepsen P, Ott P, Andersen PK, Sørensen HT, & Vilstrup H. (2010). Clinical course of cirrhosis: a population‐based cohort study of 10,044 patie… J Hepatol, 20167409.

Tsochatzis EA, Bosch J, & Burroughs AK. (2014). Liver cirrhosis. Lancet, 24622264.

See more on Doctor's Note

Q.

Stage 3 liver cirrhosis in seniors: How long can you live, realistically?

A.

For seniors with stage 3 liver cirrhosis, realistic survival is often around 1 to 3 years, though it varies widely with age, other illnesses, and control of complications; if it advances to Child-Pugh C, median survival may drop to about 6 months to 2 years. There are several factors to consider and proven steps that can improve outcomes, including transplant evaluation; see below for specific numbers, how MELD and complications change risk, and the next actions to discuss with your doctor.

References:

D'Amico G, Garcia-Tsao G, & Pagliaro L. (2006). Natural history and prognostic indicators of survival in cirrhosis… J Hepatol, 16436677.

Kamath PS, & Wiesner RH. (2001). A model to predict survival in patients with end-stage liver disea… Hepatology, 11157951.

European Association for the Study of the Liver. (2018). EASL clinical practice guidelines for the management of patients with decompensat… J Hepatol, 30125567.

See more on Doctor's Note

Q.

ELI5: What is cirrhosis of the liver?

A.

Cirrhosis is long-term scarring of the liver—repeated damage turns a soft, healthy “filter” into stiff scar tissue so it can’t clean toxins, make important proteins and bile, or control body fluids properly. It often stems from alcohol, hepatitis B/C, or fatty liver disease and can lead to swelling, confusion, bleeding, and liver cancer; there are several factors to consider—see below for full details on causes, symptoms, diagnosis, stages, treatments, and when to seek care.

References:

Schuppan D, & Afdhal NH. (2008). Liver cirrhosis. Lancet, 18280305.

D'Amico G, Garcia-Tsao G, & Pagliaro L. (2006). Natural history and prognostic indicators… Hepatology, 16378507.

Castera L, Friedrich-Rust M, & Loomba R. (2015). EASL-ALEH clinical practice guidelines: Non-invasive tests for evaluation of liver… Journal of Hepatology, 26021866.

See more on Doctor's Note

Q.

Can cirrhosis be caused by something other than alcohol?

A.

Yes, cirrhosis can be caused by things other than alcohol, such as nonalcoholic fatty liver disease and other conditions. See below to understand more.

References:

Li B, Zhang C, & Zhan YT. (2018). Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its .... Canadian journal of gastroenterology & hepatology, 30065915.

https://pubmed.ncbi.nlm.nih.gov/30065915/

Kneeman JM, Misdraji J, & Corey KE. (2012). Secondary causes of nonalcoholic fatty liver disease. Therapeutic advances in gastroenterology, 22570680.

https://pubmed.ncbi.nlm.nih.gov/22570680/

Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, & Kamath PS. (2021). Liver cirrhosis. Lancet (London, England), 34543610.

https://pubmed.ncbi.nlm.nih.gov/34543610/

See more on Doctor's Note

Q.

Can cirrhosis be stopped or reversed in stage 2 or 3?

A.

Cirrhosis in stages 2 or 3 can sometimes be slowed or improved if the cause is treated, but full reversal is rare. See below to understand more.

References:

Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, & Kamath PS. (2021). Liver cirrhosis. Lancet (London, England), 34543610.

https://pubmed.ncbi.nlm.nih.gov/34543610/

Tsochatzis EA, Bosch J, & Burroughs AK. (2014). Liver cirrhosis. Lancet (London, England), 24480518.

https://pubmed.ncbi.nlm.nih.gov/24480518/

Wazir H, Abid M, Essani B, Saeed H, Ahmad Khan M, Nasrullah F, et al. (2023). Diagnosis and Treatment of Liver Disease: Current Trends .... Cureus, 38174191.

https://pubmed.ncbi.nlm.nih.gov/38174191/

See more on Doctor's Note

Q.

Can someone live a normal life after being diagnosed with cirrhosis of the liver?

A.

Living with cirrhosis can be challenging, but with proper management, some people can maintain a good quality of life. However, cirrhosis often leads to complications that can make life unpredictable. See below to understand more.

References:

Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, & Kamath PS. (2021). Liver cirrhosis. Lancet (London, England), 34543610.

https://pubmed.ncbi.nlm.nih.gov/34543610/

Hjorth M, Svanberg A, Sjöberg D, Rorsman F, & Kaminsky E. (2020). Liver cirrhosis turns life into an unpredictable roller coaster. Journal of clinical nursing, 32888238.

https://pubmed.ncbi.nlm.nih.gov/32888238/

Heidelbaugh JJ, & Sherbondy M. (2006). Cirrhosis and chronic liver failure: part II. Complications .... American family physician, 16970020.

https://pubmed.ncbi.nlm.nih.gov/16970020/

See more on Doctor's Note

Q.

Can stage 3 liver disease still be reversed with medication or lifestyle changes?

A.

Stage 3 liver disease, known as fibrosis, can sometimes be improved with lifestyle changes and medication, but it's not always possible to reverse it completely. See below to understand more.

References:

Zoubek ME, Trautwein C, & Strnad P. (2017). Reversal of Liver Fibrosis: From Fiction to Reality. Best practice & research. Clinical gastroenterology, 28624101.

https://pubmed.ncbi.nlm.nih.gov/28624101/

Zimmermann HW, & Tacke F. (2015). can liver inflammation and fibrosis be reversed with .... Expert review of gastroenterology & hepatology, 26138749.

https://pubmed.ncbi.nlm.nih.gov/26138749/

Zhang CY, Liu S, & Yang M. (2023). Treatment of liver fibrosis: Past, current, and future. World journal of hepatology, 37397931.

https://pubmed.ncbi.nlm.nih.gov/37397931/

See more on Doctor's Note

Q.

Does cirrhosis of the liver cause pain?

A.

Yes, cirrhosis of the liver can cause pain, which is a common issue for people with this condition. See below to understand more.

References:

Rubin JB, Loeb R, Fenton C, Huang CY, Keyhani S, Seal KH, & Lai JC. (2024). The burden of significant pain in the cirrhosis population. Hepatology communications, 38780295.

https://pubmed.ncbi.nlm.nih.gov/38780295/

Holman A, Parikh N, Clauw DJ, Williams DA, & Tapper EB. (2023). Contemporary management of pain in cirrhosis. Hepatology (Baltimore, Md.), 35665522.

https://pubmed.ncbi.nlm.nih.gov/35665522/

Gorospe FFF 4th, Wong D, Lee E, Puts M, Brennenstuhl S, & Dale CM. (2025). Multidimensional Experience of Pain in Adults With Cirrhosis. Gastro hep advances, 40980074.

https://pubmed.ncbi.nlm.nih.gov/40980074/

See more on Doctor's Note

Q.

How can I tell if my cirrhosis is getting worse?

A.

Signs that cirrhosis is getting worse include increased swelling, confusion, and new bleeding. Regular check-ups and monitoring are important to manage the condition. See below to understand more.

References:

de Franchis R, & Dell'Era A. (2007). Non-invasive diagnosis of cirrhosis and the natural history .... Best practice & research. Clinical gastroenterology, 17223493.

https://pubmed.ncbi.nlm.nih.gov/17223493/

Jagdish RK, Roy A, Kumar K, Premkumar M, Sharma M, Rao PN, et al. (2023). from portal hypertension to acute-on-chronic liver failure. Frontiers in medicine, 37396918.

https://pubmed.ncbi.nlm.nih.gov/37396918/

D'Amico G, Morabito A, D'Amico M, Pasta L, Malizia G, Rebora P, & Valsecchi MG. (2018). Clinical states of cirrhosis and competing risks. Journal of hepatology, 29111320.

https://pubmed.ncbi.nlm.nih.gov/29111320/

See more on Doctor's Note

Q.

How is cirrhosis of the liver officially diagnosed?

A.

Cirrhosis of the liver is diagnosed using a combination of medical history, physical exams, blood tests, imaging tests, and sometimes a liver biopsy. See below to understand more.

References:

Smith A, Baumgartner K, & Bositis C. (2019). Cirrhosis: Diagnosis and Management. American family physician, 31845776.

https://pubmed.ncbi.nlm.nih.gov/31845776/

Gupta S, & Walker S. (2021). Testing for cirrhosis. Australian prescriber, 35002032.

https://pubmed.ncbi.nlm.nih.gov/35002032/

Heidelbaugh JJ, & Bruderly M. (2006). Cirrhosis and chronic liver failure: part I. Diagnosis and .... American family physician, 16970019.

https://pubmed.ncbi.nlm.nih.gov/16970019/

See more on Doctor's Note

Q.

How long can someone live with stage 4 cirrhosis?

A.

Stage 4 cirrhosis significantly affects life expectancy, with survival times varying widely based on individual health factors and treatment options. See below to understand more.

References:

Wedd J, Bambha KM, Stotts M, Laskey H, Colmenero J, Gralla J, & Biggins SW. (2014). Stage of cirrhosis predicts the risk of liver-related death in .... Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 24916539.

https://pubmed.ncbi.nlm.nih.gov/24916539/

Hasan I, Nababan SHH, Handayu AD, Aprilicia G, & Gani RA. (2023). Scoring system for predicting 90-day mortality of in-hospital .... BMC gastroenterology, 37264303.

https://pubmed.ncbi.nlm.nih.gov/37264303/

Goldberg D, Mantero A, Kaplan D, Delgado C, John B, Nuchovich N, et al. (2022). Accurate long-term prediction of death for patients with .... Hepatology (Baltimore, Md.), 35278226.

https://pubmed.ncbi.nlm.nih.gov/35278226/

See more on Doctor's Note

Q.

How often should someone with stage 3 liver disease get their liver checked?

A.

People with stage 3 liver disease should have their liver checked regularly, using non-invasive tests as recommended by their healthcare provider. See below to understand more.

References:

Liu SY, Wong VW, Wong SK, Wong GL, Lai CM, Lam CC, et al. (2021). A prospective 5-year study on the use of transient .... Scientific reports, 33686111.

https://pubmed.ncbi.nlm.nih.gov/33686111/

Balkhed W, Åberg FO, Nasr P, Ekstedt M, & Kechagias S. (2022). Repeated measurements of non-invasive fibrosis tests to .... Liver international : official journal of the International Association for the Study of the Liver, 35319156.

https://pubmed.ncbi.nlm.nih.gov/35319156/

Tincopa MA, & Loomba R. (2023). Non-invasive diagnosis and monitoring of non-alcoholic .... The lancet. Gastroenterology & hepatology, 37060912.

https://pubmed.ncbi.nlm.nih.gov/37060912/

See more on Doctor's Note

Q.

How quickly does stage 3 liver disease turn into cirrhosis?

A.

Stage 3 liver disease can progress to cirrhosis, but the time it takes varies for each person. Factors like the underlying cause of liver disease and lifestyle choices can influence this progression. See below to understand more.

References:

Axley P, Mudumbi S, Sarker S, Kuo YF, & Singal AK. (2018). Patients with stage 3 compared to stage 4 liver fibrosis .... PloS one, 29746540.

https://pubmed.ncbi.nlm.nih.gov/29746540/

Ng CH, Lim WH, Hui Lim GE, Hao Tan DJ, Syn N, Muthiah MD, et al. (2023). Mortality Outcomes by Fibrosis Stage in Nonalcoholic Fatty .... Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 35513235.

https://pubmed.ncbi.nlm.nih.gov/35513235/

Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, & Loomba R. (2015). Fibrosis progression in nonalcoholic fatty liver vs .... Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 24768810.

https://pubmed.ncbi.nlm.nih.gov/24768810/

See more on Doctor's Note

Q.

Is a liver transplant the only option at stage 4 cirrhosis?

A.

A liver transplant is a common treatment for stage 4 cirrhosis, but other options like auxiliary liver transplantation and potential therapies targeting HNF4α are being explored. See below to understand more.

References:

Lim C, Turco C, Balci D, Savier E, Goumard C, Perdigao F, et al. (2022). Auxiliary Liver Transplantation for Cirrhosis: From APOLT .... Annals of surgery, 34913893.

https://pubmed.ncbi.nlm.nih.gov/34913893/

Diaz-Aragon R, Coard MC, Amirneni S, Faccioli L, Haep N, Malizio MR, et al. (2021). Therapeutic Potential of HNF4α in End-stage Liver Disease. Organogenesis, 35114889.

https://pubmed.ncbi.nlm.nih.gov/35114889/

Settmacher U, Ali-Deeb A, Coubeau L, Cillo U, Line PD, Guba M, et al. (2023). Auxilliary Liver Transplantation According to the RAPID .... Annals of surgery, 36226590.

https://pubmed.ncbi.nlm.nih.gov/36226590/

See more on Doctor's Note

Q.

What are the first warning signs that cirrhosis of the liver is starting?

A.

Early signs of cirrhosis can include feeling very tired, losing your appetite, or noticing your skin and eyes turning yellow. See below to understand more.

References:

Smith A, Baumgartner K, & Bositis C. (2019). Cirrhosis: Diagnosis and Management. American family physician, 31845776.

https://pubmed.ncbi.nlm.nih.gov/31845776/

Grattagliano I, Ubaldi E, Portincasa P, & Palasciano G. (2009). Liver disease: early signs you may be missing. The Journal of family practice, 19874729.

https://pubmed.ncbi.nlm.nih.gov/19874729/

Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, & Kamath PS. (2021). Liver cirrhosis. Lancet (London, England), 34543610.

https://pubmed.ncbi.nlm.nih.gov/34543610/

See more on Doctor's Note

Q.

What counts as stage 3 liver disease, and how is it different from stage 2 or stage 4?

A.

Stage 3 liver disease involves significant liver scarring. It's more advanced than stage 2 but not as severe as stage 4, which includes cirrhosis. See below to understand more.

References:

Sánchez-Azofra M, Fernández I, García-Buey ML, Domínguez-Domínguez L, Fernández-Rodríguez CM, Mancebo A, et al. (2021). Hepatocellular carcinoma risk in hepatitis C stage-3 .... Liver international : official journal of the International Association for the Study of the Liver, 34392590.

https://pubmed.ncbi.nlm.nih.gov/34392590/

Ekstedt M, Hagström H, Nasr P, Fredrikson M, Stål P, Kechagias S, & Hultcrantz R. (2015). Fibrosis stage is the strongest predictor for disease-specific .... Hepatology (Baltimore, Md.), 25125077.

https://pubmed.ncbi.nlm.nih.gov/25125077/

Hagström H, Kechagias S, & Ekstedt M. (2022). Risk for hepatic and extra-hepatic outcomes in .... Journal of internal medicine, 34118091.

https://pubmed.ncbi.nlm.nih.gov/34118091/

See more on Doctor's Note

Q.

What does stage 4 cirrhosis mean in terms of liver failure?

A.

Stage 4 cirrhosis means the liver is very damaged and not working well, which can lead to serious health problems and a higher risk of death. See below to understand more.

References:

Wedd J, Bambha KM, Stotts M, Laskey H, Colmenero J, Gralla J, & Biggins SW. (2014). Stage of cirrhosis predicts the risk of liver-related death in .... Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 24916539.

https://pubmed.ncbi.nlm.nih.gov/24916539/

Axley P, Mudumbi S, Sarker S, Kuo YF, & Singal AK. (2018). Patients with stage 3 compared to stage 4 liver fibrosis .... PloS one, 29746540.

https://pubmed.ncbi.nlm.nih.gov/29746540/

Goodman ZD. (2007). Grading and staging systems for inflammation and fibrosis .... Journal of hepatology, 17692984.

https://pubmed.ncbi.nlm.nih.gov/17692984/

See more on Doctor's Note

Q.

What is the life expectancy for someone in stage 4 cirrhosis?

A.

Life expectancy for someone with stage 4 cirrhosis can be quite limited, often measured in months to a few years, depending on complications and overall health. See below to understand more.

References:

de Franchis R, & Dell'Era A. (2007). Non-invasive diagnosis of cirrhosis and the natural history .... Best practice & research. Clinical gastroenterology, 17223493.

https://pubmed.ncbi.nlm.nih.gov/17223493/

Wedd J, Bambha KM, Stotts M, Laskey H, Colmenero J, Gralla J, & Biggins SW. (2014). Stage of cirrhosis predicts the risk of liver-related death in .... Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 24916539.

https://pubmed.ncbi.nlm.nih.gov/24916539/

Zipprich A, Garcia-Tsao G, Rogowski S, Fleig WE, Seufferlein T, & Dollinger MM. (2012). Prognostic indicators of survival in patients with .... Liver international : official journal of the International Association for the Study of the Liver, 22679906.

https://pubmed.ncbi.nlm.nih.gov/22679906/

See more on Doctor's Note

Q.

What medications are safest for someone with cirrhosis?

A.

In people with cirrhosis, medication choices need to be made carefully to avoid liver damage. Many common drugs need dose adjustments or should be avoided entirely. See below to understand more.

References:

Weersink RA, Burger DM, Hayward KL, Taxis K, Drenth JPH, & Borgsteede SD. (2020). Safe use of medication in patients with cirrhosis. Expert opinion on drug metabolism & toxicology, 31810397.

https://pubmed.ncbi.nlm.nih.gov/31810397/

Amarapurkar DN. (2011). Prescribing medications in patients with decompensated .... International journal of hepatology, 21994861.

https://pubmed.ncbi.nlm.nih.gov/21994861/

Westphal JF, & Brogard JM. (1997). Drug administration in chronic liver disease. Drug safety, 9258630.

https://pubmed.ncbi.nlm.nih.gov/9258630/

See more on Doctor's Note

Q.

What other health problems can cirrhosis lead to?

A.

Cirrhosis can lead to many health problems like fluid buildup in the belly, confusion, and bleeding easily. It can also cause problems with the kidneys and make you more likely to get infections. See below to understand more.

References:

Premkumar M, & Anand AC. (2022). Overview of Complications in Cirrhosis. Journal of clinical and experimental hepatology, 35814522.

https://pubmed.ncbi.nlm.nih.gov/35814522/

Reincke M, Thimme R, & Schultheiß M. (2023). [Complications of liver cirrhosis]. Deutsche medizinische Wochenschrift (1946), 37820648.

https://pubmed.ncbi.nlm.nih.gov/37820648/

Nusrat S, Khan MS, Fazili J, & Madhoun MF. (2014). Cirrhosis and its complications: evidence based treatment. World journal of gastroenterology, 24833875.

https://pubmed.ncbi.nlm.nih.gov/24833875/

See more on Doctor's Note

Q.

What symptoms should I expect in stage 4 cirrhosis on a daily basis?

A.

In stage 4 cirrhosis, you may experience tiredness, confusion, swelling, and trouble eating. It’s important to manage these symptoms with your healthcare provider. See below to understand more.

References:

Foster C, Baki J, Nikirk S, Williams S, Parikh ND, & Tapper EB. (2020). Comprehensive Health-State Utilities in Contemporary .... Hepatology communications, 32490321.

https://pubmed.ncbi.nlm.nih.gov/32490321/

Tapper EB, Baki J, Parikh ND, & Lok AS. (2019). Frailty, Psychoactive Medications, and Cognitive .... Hepatology (Baltimore, Md.), 30382584.

https://pubmed.ncbi.nlm.nih.gov/30382584/

Faccioli J, Nardelli S, Gioia S, Riggio O, & Ridola L. (2022). Nutrition Assessment and Management in Patients with .... Journal of clinical medicine, 35628968.

https://pubmed.ncbi.nlm.nih.gov/35628968/

See more on Doctor's Note

Q.

What foods are bad for the liver?

A.

A diet high in sugar (especially fructose), saturated and trans fats, refined carbohydrates, and excessive alcohol is harmful to the liver.

References:

Berná G, Romero-Gomez M. The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and management. Liver Int. 2020 Feb;40 Suppl 1:102-108. doi: 10.1111/liv.14360. PMID: 32077594.

Salehi-Sahlabadi A, Sadat S, Beigrezaei S, Pourmasomi M, Feizi A, Ghiasvand R, Hadi A, Clark CCT, Miraghajani M. Dietary patterns and risk of non-alcoholic fatty liver disease. BMC Gastroenterol. 2021 Jan 28;21(1):41. doi: 10.1186/s12876-021-01612-z. PMID: 33509112; PMCID: PMC7844966.

Zelber-Sagi S, Salomone F, Mlynarsky L. The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. Liver Int. 2017 Jul;37(7):936-949. doi: 10.1111/liv.13435. Epub 2017 Jun 1. PMID: 28371239.

See more on Doctor's Note

Q.

What foods are good for the liver?

A.

Foods that are good for your body are the same ones that are good for your liver. These include whole-foods that are high in fiber and unprocessed.

References:

Montemayor S, García S, Monserrat-Mesquida M, Tur JA, Bouzas C. Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review. Nutrients. 2023 Sep 14;15(18):3987. doi: 10.3390/nu15183987. PMID: 37764771; PMCID: PMC10534915.

George ES, Forsyth A, Itsiopoulos C, Nicoll AJ, Ryan M, Sood S, Roberts SK, Tierney AC. Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in Adults. Adv Nutr. 2018 Jan 1;9(1):30-40. doi: 10.1093/advances/nmx007. PMID: 29438460; PMCID: PMC6333937.

Berná G, Romero-Gomez M. The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and management. Liver Int. 2020 Feb;40 Suppl 1:102-108. doi: 10.1111/liv.14360. PMID: 32077594.

See more on Doctor's Note

Q.

What is the life expectancy for stage 3 and stage 4 cirrhosis?

A.

The life expectancy for individuals with cirrhosis varies significantly between stages 3 and 4. Generally, patients with stage 3 cirrhosis have a better prognosis than those with stage 4 cirrhosis, as the latter is associated with more severe liver damage and complications.

References:

Kumar R, Kumar S, Prakash SS. Compensated liver cirrhosis: Natural course and disease-modifying strategies. World J Methodol. 2023 Sep 20;13(4):179-193. doi: 10.5662/wjm.v13.i4.179. PMID: 37771878; PMCID: PMC10523240.

Axley P, Mudumbi S, Sarker S, Kuo YF, Singal AK. Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications. PLoS One. 2018 May 10;13(5):e0197117. doi: 10.1371/journal.pone.0197117. Erratum in: PLoS One. 2018 Aug 2;13(8):e0199402. doi: 10.1371/journal.pone.0199402. PMID: 29746540; PMCID: PMC5944985.

Mallik M, Singhai A, Khadanga S, Ingle V. The Significant Morbidity and Mortality Indicators in Patients of Cirrhosis. Cureus. 2022 Jan 14;14(1):e21226. doi: 10.7759/cureus.21226. PMID: 35174029; PMCID: PMC8841014.

See more on Doctor's Note

Ubie is supervised by 50+ medical experts worldwide

Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.

Maxwell J. Nanes, DO

Maxwell J. Nanes, DO

Emergency Medicine

Waukesha Memorial Hospital, Waukesha Wisconsin, USA

Caroline M. Doan, DO

Caroline M. Doan, DO

Internal Medicine

Signify Health

Benjamin Kummer, MD

Benjamin Kummer, MD

Neurology, Clinical Informatics

Icahn School of Medicine at Mount Sinai

Charles Carlson, DO, MS

Charles Carlson, DO, MS

Psychiatry

U.S. Department of Veterans Affairs

Dale Mueller, MD

Dale Mueller, MD

Cardiothoracic and Vascular Surgery

Cardiothoracic and Vascular Surgery Associates

Ravi P. Chokshi, MD

Ravi P. Chokshi, MD

Obstetrics and gynecology

Penn State Health

Ubie is recognized by healthcare and tech leaders

Newsweek 2024

“World’s Best Digital
Health Companies”

Newsweek 2024

Google Play Best of 2023

“Best With AI”

Google Play Best of 2023

Digital Health Awards 2023

“Best in Class”

Digital Health Awards 2023 (Quarterfinalist)

Which is the best Symptom Checker?

Which is the best Symptom Checker?

Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.

Link to full study:

https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1

References